Search

everythinglearnresearchcommunity

for

Search:↓

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

PRP injections improve intestinal healing in rabbits with fewer complications than soaking.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

Injectable platelet-rich fibrin can safely and effectively treat melasma.

AMP-303 safely increases hair growth in men with hair loss.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Ritlecitinib can help about 14,000 people with severe hair loss.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

Miliacin with polar lipids helps hair growth and improves hair loss in women.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Valproic acid effectively reduces aggressive and impulsive behaviors in brain injury patients with acceptable side effects.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Combining Pulsed Dye Laser with Pingyangmycin is effective and safe for treating acne scars.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Targeting PTEN can improve healing in venous leg ulcers.

New therapies are being developed that target integrin pathways to treat various diseases.

A Labrador Retriever with pemphigus fully recovered after six weeks of azathioprine treatment.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.